Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(15), P. 4560 - 4560
Published: Aug. 4, 2022
Background:
Cutaneous
melanoma
is
a
heterogeneous
tumor
with
rapidly
switching
molecular
and
cellular
phenotype.
The
invasive
phenotype
characterized
by
MITFlow/AXLhigh
predicts
early
resistance
to
multiple
targeted
drugs
in
melanoma.
Celecoxib
proved
be
valuable
adjuvant
cutaneous
preclinical
studies.
Our
vitro
study
evaluated
for
the
first
time
whether
celecoxib
could
prevent
two
human
cell
lines
treated
dabrafenib.
Methods:
All
experiments
were
carried
out
on
BRAF-V600E-positive
A375
SK-MEL-28
lines,
subjected
dabrafenib
drug
combination
72
h.
Melanoma
cells
already
end
of
spectrum.
Of
main
interest
was
evaluation
key
proteins
expressed
(TGF-β,
MITF,
AXL,
YAP,
TAZ),
as
well
death
mechanisms
correlated
oxidative
stress
production.
Results:
significantly
enhanced
apoptotic
effect
each
line
compared
group
(p
<
0.0001).
Even
though
promoted
low
MITF
expression,
this
high
receptor
tyrosine
kinase
AXL
levels
0.0001),
positive
marker
switch
an
state.
Conclusion:
This
preliminary
highlighted
that
might
promote
expression
dabrafenib,
facilitating
vitro.
results
need
further
confirmation,
finding
represent
important
limitation
antineoplastic
drug.
Oncogene,
Journal Year:
2020,
Volume and Issue:
40(5), P. 1027 - 1042
Published: Dec. 15, 2020
Abstract
Dysregulation
of
the
Wnt/β-catenin
signaling
pathway
is
critically
involved
in
gastric
cancer
(GC)
progression.
However,
current
Wnt
inhibitors
being
studied
preclinical
or
clinical
settings
for
other
cancers
such
as
colorectal
and
pancreatic
are
either
too
cytotoxic
insufficiently
efficacious
GC.
Thus,
we
screened
new
potent
targets
from
β-catenin
destruction
complex
associated
with
GC
progression
samples,
found
that
scaffolding
protein
RACK1
deficiency
plays
a
significant
role
progression,
but
not
APC,
AXIN,
GSK3β.
Then,
identified
its
upstream
regulator
UBE2T
which
promotes
via
hyperactivating
through
ubiquitination
degradation
at
lysine
K172,
K225,
K257
residues
independent
an
E3
ligase.
Indeed,
level
negatively
prognosis
patients,
suggesting
promising
target
therapy.
Furthermore,
novel
inhibitor,
M435-1279,
suggested
M435-1279
acts
inhibit
hyperactivation
blocking
UBE2T-mediated
RACK1,
resulting
suppression
lower
cytotoxicity
meantime.
Overall,
increased
levels
promote
inhibitor
providing
balance
between
growth
inhibition
well,
offer
opportunity
specific
patients
aberrant
signaling.
Journal of Cellular Physiology,
Journal Year:
2021,
Volume and Issue:
237(1), P. 199 - 238
Published: Aug. 25, 2021
Abstract
Several
signaling
pathways
have
been
identified
as
important
for
developmental
processes.
One
of
such
cascades
is
the
Wnt/β‐catenin
pathway,
which
can
regulate
various
physiological
processes
embryonic
development,
tissue
homeostasis,
and
regeneration;
while
its
dysregulation
implicated
in
several
pathological
conditions
especially
cancers.
Interestingly,
deregulation
pathway
has
reported
to
be
closely
associated
with
initiation,
progression,
metastasis,
maintenance
cancer
stem
cells,
drug
resistance
human
malignancies.
Moreover,
genetic
experimental
models
support
inhibition
answer
key
issues
related
development.
The
present
review
focuses
on
different
regulators
Wnt
how
distinct
mutations,
deletion,
amplification
these
could
possibly
play
an
essential
role
development
cancers
colorectal,
melanoma,
breast,
lung,
leukemia.
Additionally,
we
also
provide
insights
diverse
classes
inhibitors
are
currently
preclinical
clinical
trial
against
Cancers,
Journal Year:
2025,
Volume and Issue:
17(2), P. 194 - 194
Published: Jan. 9, 2025
Prostate
cancer
is
one
of
the
most
common
diseases
among
men
worldwide
and
continues
to
pose
a
serious
threat
health.
This
review
shows
history
new
developments
in
management
prostate
cancer,
with
an
emphasis
on
range
therapeutic
approaches,
such
as
hormone
therapy,
radiation
surgery,
innovative
targeted
therapeutics.
The
evolution
these
treatments
examined
light
clinical
outcomes,
patient
quality
life,
emerging
resistance
mechanisms,
recently
shown
vitamin
D-based
strategies.
New
that
have
potential
increase
survival
rates
reduce
side
effects
are
also
discussed,
including
PARP
inhibitors
(PARPis),
immunotherapy,
tailored
medication.
Additionally,
use
biomarkers
sophisticated
imaging
methods
decision-making
explored,
focus
how
tools
might
improve
care.
absolute
necessity
for
multidisciplinary
approach
improving
treatment
strategies
becoming
more
apparent
our
understanding
biology
deepens.
ensures
patients
receive
customized
medicines
fit
their
unique
profiles.
Future
avenues
investigation
will
resolving
issues
dealing
efficacy
results,
ultimately
leading
disease
cure
patients.
OMICS A Journal of Integrative Biology,
Journal Year:
2020,
Volume and Issue:
24(4), P. 175 - 179
Published: March 16, 2020
A
bottleneck
that
is
hindering
therapeutics
innovation
in
cancers
the
current
lack
of
integration
what
we
have
learned
tumor
biology
as
well
microenvironment
(TME).
This
because
tumors
are
complex
tissues
composed
cancer
cells,
stromal
and
extracellular
matrix
(ECM).
Although
genetic
alterations
might
cause
initial
uncontrolled
growth,
resistance
to
apoptosis
cells
play
additional
key
roles
within
TME
thus
influence
initiation,
progression,
therapy
resistance,
metastasis.
Therapies
targeting
usually
insufficient
when
component
causes
resistance.
For
treatment
take
a
full
snapshot
biology,
anticancer
drug
design
must,
therefore,
target
both
component.
expert
review
critically
examines
components
such
cancer-associated
fibroblasts
ECM
can
be
reprogrammed
create
tumor-suppressive
environment,
thereby
aiding
treatment.
Better
experimental
models
mimic
spheroids,
microfluidics,
three
dimensional
(3D)
bioprinted
models,
organoids
will
allow
deeper
investigations
complexity
lead
translation
basic
effective
treatments.
Ultimately,
innovative
treatments
and,
by
extension,
improvement
patients'
outcomes
emerge
from
combinatorial
development
strategies
TME.
Combinatorial
form
chemotherapy
radiotherapy
(targeting
components)
immunotherapy
able
regulate
immune
responses
against
cells.
addresses
previously
neglected
knowledge
gap
broadening
focus
so
empower
disruptive
health
care
innovations
oncology
clinic.
World Journal of Gastrointestinal Oncology,
Journal Year:
2022,
Volume and Issue:
14(1), P. 124 - 152
Published: Jan. 10, 2022
Artificial
intelligence
(AI)
technology
has
made
leaps
and
bounds
since
its
invention.
AI
can
be
subdivided
into
many
technologies
such
as
machine
learning
deep
learning.
The
application
scope
prospect
of
different
are
also
totally
different.
Currently,
play
a
pivotal
role
in
the
highly
complex
wide-ranging
medical
field,
image
recognition,
biotechnology,
auxiliary
diagnosis,
drug
research
development,
nutrition.
Colorectal
cancer
(CRC)
is
common
gastrointestinal
that
high
mortality,
posing
serious
threat
to
human
health.
Many
CRCs
caused
by
malignant
transformation
colorectal
polyps.
Therefore,
early
diagnosis
treatment
crucial
CRC
prognosis.
methods
diagnosing
divided
imaging
endoscopy,
pathology
diagnosis.
Treatment
endoscopic
treatment,
surgical
treatment.
weak
era
does
not
have
communication
capabilities.
current
mainly
used
for
recognition
analysis
without
in-depth
with
patients.
This
article
reviews
prognosis
provides
prospects
broader
CRC.
Phytotherapy Research,
Journal Year:
2023,
Volume and Issue:
37(4), P. 1606 - 1623
Published: Feb. 9, 2023
Abstract
Cancer
is
the
leading
cause
of
mortality
and
morbidity
worldwide,
its
cases
are
rapidly
increasing
every
year.
Several
factors
contribute
to
development
tumorigenesis.
including
radiation,
dietary
lifestyle,
smoking,
environmental,
genetic
factors.
The
cell
cycle
regulated
by
a
variety
molecular
signaling
proteins.
However,
when
proteins
involved
in
regulation
altered,
cellular
growth
proliferation
significantly
affected.
Natural
products
provide
an
important
source
new
drug
for
ailments.
cancer.
Phytosterols
(PSs)
class
natural
compounds
reported
numerous
pharmacological
activities,
Various
PSs,
such
as
ergosterol,
stigmasterol,
sitosterol,
withaferin
A,
etc.,
have
been
their
anti‐cancer
activities
against
cancer
modulating
tumor
microenvironment
via
pathways
discussed
within
article.
These
associated
with
production
pro‐inflammatory
mediators,
factors,
chemokines,
pro‐apoptotic
anti‐apoptotic
genes.
mediators
upstream
very
active
tumors
these
signalings,
thus
PS
exhibits
promising
activities.
further
high‐quality
studies
needed
firmly
establish
clinical
efficacy
well
safety
phytosterols.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: April 23, 2025
Introduction
This
review
examines
quantum
computing
(QC)
applications
in
clinical
care,
emphasizing
advancements
directly
impacting
patient
outcomes.
QC
holds
transformative
potential
medicine,
particularly
through
enhancing
diagnostic
accuracy,
optimizing
treatment
plans,
and
enabling
real-time
decision-making.
Methods
A
systematic
analysis
of
35
studies
published
between
2015
2024
was
conducted.
The
were
evaluated
for
their
contributions
to
diagnostic,
therapeutic,
decision-support
improvements
care
enabled
by
technologies.
Results
revealed
QC’s
promise
improving
accuracy
medical
imaging,
treatments
oncology,
QC-driven
algorithms
demonstrated
enhance
computational
efficiency.
These
could
enable
earlier
detection
diseases
such
as
Alzheimer’s,
cancer,
osteoarthritis,
supporting
more
timely
interventions
better
prognoses.
Discussion
Despite
promising
outcomes,
current
limitations—such
hardware
scalability,
error
mitigation,
ethical
considerations—hinder
widespread
adoption
settings.
Overcoming
these
challenges
will
require
interdisciplinary
collaboration
technological
innovation.
underscores
capacity
deliver
precise,
personalized,
efficient
advocating
its
integration
into
healthcare
workflows
advance
precision
medicine
improve
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(9), P. 2088 - 2088
Published: April 26, 2023
The
Wnt
pathway
has
been
recognized
for
its
crucial
role
in
human
development
and
homeostasis,
but
dysregulation
also
linked
to
several
disorders,
including
cancer.
signaling
is
the
metastasis
of
kinds
Moreover,
members
have
proven
be
effective
biomarkers
promising
cancer
therapeutic
targets.
Abnormal
stimulation
initiation
advancement
both
clinical
research
vitro
investigations.
A
reduction
incidence
rate
an
improvement
survival
may
result
from
targeting
Wnt/β-catenin
pathway.
As
a
result,
blocking
this
focus
research,
candidates
that
can
targeted
are
currently
being
developed.
Flavonoids
derived
plants
exhibit
growth
inhibitory,
apoptotic,
anti-angiogenic,
anti-migratory
effects
against
various
malignancies.
flavonoids
influence
different
pathways,
Wnt,
exert
their
anticancer
effects.
In
review,
we
comprehensively
evaluate
on
by
focusing
pathway,
provide
evidence
impact
number
molecular
Overall,
review
will
enhance
our
understanding
these
natural
products
as
modulators.
OMICS A Journal of Integrative Biology,
Journal Year:
2020,
Volume and Issue:
24(6), P. 340 - 351
Published: June 1, 2020
Solid
tumors
have
complex
biology
and
structure
comprising
cancer
cells,
stromal
the
extracellular
matrix.
While
most
therapeutics
target
recent
data
suggest
that
cell
behavior
response
to
treatment
are
markedly
influenced
by
tumor
microenvironment
(TME).
In
particular,
cancer-associated
fibroblasts
(CAFs)
abundant
play
a
significant
contextual
role
in
shaping
initiation,
progression,
metastasis.
CAFs
therefore
emerged
as
part
of
next-generation
drug
design
discovery
innovation
strategy.
We
report
here
new
findings
on
differential
expression
prognostic
significance
CAF
markers
several
cancers.
utilized
two
publicly
available
resources:
The
Cancer
Genomic
Atlas
Gene
Expression
Profiling
Interactive
Analysis.
examined
markers,
ACTA2,
S100A4,
platelet-derived
growth
factor
receptor-beta
[PDGFR-β],
CD10,
fibroblast
activation
protein-alpha
(FAP-α),
tissues
versus
adjacent
normal
tissues.
found
were
differentially
expressed
various
different
such
colon,
breast,
esophageal
cancers
melanoma.
No
marker
is
same
pattern
all
cancers,
however.
Importantly,
we
patients
with
colon
adenocarcinoma
carcinoma
expressing
high
FAP-α
respectively,
had
significantly
shorter
overall
survival,
compared
those
low
levels
these
(p
<
0.05).
call
for
continued
research
TME
clinical
evaluation
PDGFR-β,
relation
prognosis
solid
large
population
samples.
An
effective
roadmap
21st
century
ought
be
broadly
framed,
include
molecular
targets
informed
both
variations.